vs

Side-by-side financial comparison of MasterCraft Boat Holdings, Inc. (MCFT) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $78.2M, roughly 1.1× MasterCraft Boat Holdings, Inc.). MasterCraft Boat Holdings, Inc. runs the higher net margin — 4.8% vs -38.1%, a 42.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 3.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -8.9%).

The MasterCraft Boat Company is an American manufacturer of luxury high-performance boats. The company was founded in 1968 in Maryville, Tennessee, and is currently headquartered in Vonore, Tennessee. MasterCraft boats are used in waterskiing, wakeboarding and wake surfing.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

MCFT vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$83.1M
$78.2M
MCFT
Growing faster (revenue YoY)
PRCT
PRCT
+17.2% gap
PRCT
20.2%
3.0%
MCFT
Higher net margin
MCFT
MCFT
42.8% more per $
MCFT
4.8%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
-8.9%
MCFT

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
MCFT
MCFT
PRCT
PRCT
Revenue
$78.2M
$83.1M
Net Profit
$3.7M
$-31.6M
Gross Margin
25.0%
64.9%
Operating Margin
73.4%
-4.1%
Net Margin
4.8%
-38.1%
Revenue YoY
3.0%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.45
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MCFT
MCFT
PRCT
PRCT
Q1 26
$78.2M
$83.1M
Q4 25
$71.8M
$76.4M
Q3 25
$69.0M
$83.3M
Q2 25
$79.5M
$79.2M
Q1 25
$76.0M
$69.2M
Q4 24
$63.4M
$68.2M
Q3 24
$65.4M
$58.4M
Q2 24
$94.3M
$53.4M
Net Profit
MCFT
MCFT
PRCT
PRCT
Q1 26
$3.7M
$-31.6M
Q4 25
$2.5M
$-29.8M
Q3 25
$3.6M
$-21.4M
Q2 25
$5.7M
$-19.6M
Q1 25
$3.7M
$-24.7M
Q4 24
$2.7M
$-18.9M
Q3 24
$-5.1M
$-21.0M
Q2 24
$6.2M
$-25.6M
Gross Margin
MCFT
MCFT
PRCT
PRCT
Q1 26
25.0%
64.9%
Q4 25
21.6%
60.6%
Q3 25
22.3%
64.8%
Q2 25
23.2%
65.4%
Q1 25
20.8%
63.9%
Q4 24
17.2%
64.0%
Q3 24
18.1%
63.2%
Q2 24
23.8%
59.0%
Operating Margin
MCFT
MCFT
PRCT
PRCT
Q1 26
73.4%
-4.1%
Q4 25
3.8%
-40.6%
Q3 25
5.5%
-27.8%
Q2 25
7.5%
-28.0%
Q1 25
5.4%
-39.7%
Q4 24
0.3%
-28.9%
Q3 24
1.5%
-38.4%
Q2 24
11.2%
-50.3%
Net Margin
MCFT
MCFT
PRCT
PRCT
Q1 26
4.8%
-38.1%
Q4 25
3.5%
-39.1%
Q3 25
5.3%
-25.7%
Q2 25
7.2%
-24.7%
Q1 25
4.9%
-35.8%
Q4 24
4.3%
-27.6%
Q3 24
-7.9%
-35.9%
Q2 24
6.6%
-48.0%
EPS (diluted)
MCFT
MCFT
PRCT
PRCT
Q1 26
$0.45
$-0.56
Q4 25
$0.16
$-0.54
Q3 25
$0.22
$-0.38
Q2 25
$0.34
$-0.35
Q1 25
$0.23
$-0.45
Q4 24
$0.17
$-0.34
Q3 24
$-0.31
$-0.40
Q2 24
$0.38
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MCFT
MCFT
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$84.6M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$189.3M
$347.7M
Total Assets
$277.9M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MCFT
MCFT
PRCT
PRCT
Q1 26
$84.6M
$245.6M
Q4 25
$81.4M
$286.5M
Q3 25
$67.3M
$294.3M
Q2 25
$79.4M
$302.7M
Q1 25
$66.5M
$316.2M
Q4 24
$62.9M
$333.7M
Q3 24
$14.2M
$196.8M
Q2 24
$86.2M
$214.1M
Total Debt
MCFT
MCFT
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$49.5M
$51.4M
Q2 24
$49.3M
$51.4M
Stockholders' Equity
MCFT
MCFT
PRCT
PRCT
Q1 26
$189.3M
$347.7M
Q4 25
$189.1M
$365.9M
Q3 25
$185.5M
$380.3M
Q2 25
$183.4M
$385.8M
Q1 25
$182.1M
$389.2M
Q4 24
$178.3M
$402.2M
Q3 24
$175.4M
$241.2M
Q2 24
$183.7M
$251.8M
Total Assets
MCFT
MCFT
PRCT
PRCT
Q1 26
$277.9M
$487.1M
Q4 25
$259.7M
$508.1M
Q3 25
$259.3M
$511.5M
Q2 25
$259.9M
$513.1M
Q1 25
$261.9M
$519.4M
Q4 24
$250.1M
$534.0M
Q3 24
$309.1M
$374.1M
Q2 24
$259.9M
$374.4M
Debt / Equity
MCFT
MCFT
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.28×
0.21×
Q2 24
0.27×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MCFT
MCFT
PRCT
PRCT
Operating Cash FlowLast quarter
$13.4M
Free Cash FlowOCF − Capex
$7.6M
FCF MarginFCF / Revenue
9.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.58×
TTM Free Cash FlowTrailing 4 quarters
$29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MCFT
MCFT
PRCT
PRCT
Q1 26
$13.4M
Q4 25
$15.6M
$-10.3M
Q3 25
$-6.8M
$-6.6M
Q2 25
$20.4M
$-15.0M
Q1 25
$6.3M
$-17.0M
Q4 24
$6.4M
$-32.4M
Q3 24
$2.4M
$-18.8M
Q2 24
$-15.7M
Free Cash Flow
MCFT
MCFT
PRCT
PRCT
Q1 26
$7.6M
Q4 25
$14.0M
$-12.2M
Q3 25
$-9.9M
$-9.5M
Q2 25
$17.9M
$-17.8M
Q1 25
$4.3M
$-18.8M
Q4 24
$4.0M
$-33.6M
Q3 24
$199.0K
$-19.0M
Q2 24
$-16.8M
FCF Margin
MCFT
MCFT
PRCT
PRCT
Q1 26
9.8%
Q4 25
19.5%
-15.9%
Q3 25
-14.4%
-11.4%
Q2 25
22.5%
-22.5%
Q1 25
5.7%
-27.2%
Q4 24
6.4%
-49.2%
Q3 24
0.3%
-32.6%
Q2 24
-31.4%
Capex Intensity
MCFT
MCFT
PRCT
PRCT
Q1 26
Q4 25
2.3%
2.4%
Q3 25
4.5%
3.4%
Q2 25
3.3%
3.5%
Q1 25
2.6%
2.7%
Q4 24
3.8%
1.7%
Q3 24
3.4%
0.4%
Q2 24
2.0%
Cash Conversion
MCFT
MCFT
PRCT
PRCT
Q1 26
3.58×
Q4 25
6.17×
Q3 25
-1.88×
Q2 25
3.59×
Q1 25
1.69×
Q4 24
2.34×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MCFT
MCFT

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons